GPX8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.092800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.415000E-01
Normal-vs-Stage2
7.304200E-01
Normal-vs-Stage3
6.264200E-01
Normal-vs-Stage4
5.465800E-01
Stage1-vs-Stage2
3.010600E-01
Stage1-vs-Stage3
2.898000E-01
Stage1-vs-Stage4
1.902040E-01
Stage2-vs-Stage3
4.171400E-01
Stage2-vs-Stage4
3.684200E-01
Stage3-vs-Stage4
9.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.393400E-01
Normal-vs-AfricanAmerican
7.480400E-01
Normal-vs-Asian
9.199600E-01
Caucasian-vs-AfricanAmerican
6.246200E-01
Caucasian-vs-Asian
8.558400E-01
AfricanAmerican-vs-Asian
6.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.346000E-01
Normal-vs-Female
7.671200E-01
Male-vs-Female
8.545400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.453400E-01
Normal-vs-Age(41-60Yrs)
5.375000E-01
Normal-vs-Age(61-80Yrs)
9.017800E-01
Normal-vs-Age(81-100Yrs)
9.325000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.322630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.979800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.712400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.435640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.225200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.954200E-01
Normal-vs-Daily Drinker
6.023400E-01
Normal-vs-Weekly Drinker
6.567400E-01
Normal-vs-Occasional Drinker
9.490200E-01
Normal-vs-Social Drinker
6.643000E-01
Non Drinker-vs-Daily Drinker
5.346600E-01
Non Drinker-vs-Weekly Drinker
1.272580E-01
Non Drinker-vs-Occasional Drinker
5.840200E-01
Non Drinker-vs-Social Drinker
1.878650E-01
Daily Drinker-vs-Weekly Drinker
5.886200E-02
Daily Drinker-vs-Occasional Drinker
3.526000E-01
Daily Drinker-vs-Social Drinker
1.020040E-01
Weekly Drinker-vs-Occasional Drinker
5.503800E-01
Weekly Drinker-vs-Social Drinker
8.876200E-01
Occasional Drinker-vs-Social Drinker
4.929600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.313800E-01
Normal-vs-Grade 2
2.223600E-01
Normal-vs-Grade 3
4.187600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.90799999997016E-06
Grade 1-vs-Grade 3
3.316300E-03
Grade 1-vs-Grade 4
9.313800E-01
Grade 2-vs-Grade 3
4.538200E-01
Grade 2-vs-Grade 4
2.223600E-01
Grade 3-vs-Grade 4
4.187600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.358600E-01
Normal-vs-NonDiabetic
8.923600E-01
Diabetic-vs-NonDiabetic
8.907600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.569400E-01
Normal-vs-NoPancreatitis
8.672400E-01
Pancreatitis-vs-NoPancreatitis
9.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.306200E-01
Normal-vs-N1
6.982400E-01
N0-vs-N1
3.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.947600E-01
Normal-vs-TP53-NonMutant
7.663600E-01
TP53-Mutant-vs-TP53-NonMutant
1.962470E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
